Permanent - Genitourinary Cancer - Georgia
- Location
- Georgia
- Type
- Permanent
- Job #
- 5368
GU Cancer | Southeast | Academic
Our client is seeking a candidate who is interested in academic Genitourinary Medical Oncology. Some details regarding the position are below:
-
Academic Genitourinary (GU) Medical Oncology position focused on prostate, bladder, kidney, testicular, and other GU cancers.
-
Join a multidisciplinary cancer program collaborating closely with urology, radiation oncology, pathology, and radiology.
-
Opportunity to develop expertise in advanced GU therapies, including immunotherapy, targeted therapies, radioligand therapy, and precision oncology approaches.
-
Teaching responsibilities include mentoring fellows and participating in academic education programs.
-
Protected research time available with opportunities to participate in clinical trials and expand the GU oncology research portfolio.
-
Call schedule is relatively infrequent, with strong support from fellows, residents, advanced practice providers, and nursing staff.
-
Each physician receives dedicated APP and clinic nurse support to enhance patient care and workflow efficiency.
-
Open to both experienced physicians and fellowship graduates; candidates interested in pursuing an academic subspecialty focus are encouraged to apply.
-
Visa sponsorship options are available for qualified candidates.
Your Assurgent recruiter for this search.
Apply with Assurgent.
Your CV goes straight to the Assurgent team working this search, not to a general inbox. If it is not the right fit, they will tell you what is.
Assurgent Medical Staffing is an equal opportunity employer and places clinicians without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.
Similar roles.
All Hematology Oncology rolesStart a conversation
Rather talk it through first?
Call Assurgent and ask for the team working this search. Ask about the call structure, the group, and what the last person in the role said about it.
